Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, India Glycols's Enterprise Value is ₹57,756 Mil.
India Glycols's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₹4,031 Mil. Therefore, India Glycols's EV-to-EBIT ratio for today is 14.33.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, India Glycols's Enterprise Value is ₹57,756 Mil.
India Glycols's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was ₹5,117 Mil. Therefore, India Glycols's EV-to-EBITDA ratio for today is 11.29.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, India Glycols's Enterprise Value is ₹57,756 Mil.
India Glycols's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₹38,059 Mil. Therefore, India Glycols's EV-to-Revenue ratio for today is 1.52.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, India Glycols's Enterprise Value is ₹57,756 Mil.
India Glycols's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil. Therefore, India Glycols's EV-to-FCF ratio for today is .
India Glycols Enterprise Value Historical Data
The historical data trend for India Glycols's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of India Glycols's Enterprise Value
For the Chemicals subindustry, India Glycols's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols's Enterprise Value Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Enterprise Value distribution charts can be found below:
* The bar in red indicates where India Glycols's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
India Glycols's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols (BOM:500201) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
India Glycols's current Enterprise Value is ₹57,756 Mil.
India Glycols's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,031 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
India Glycols's current Enterprise Value is ₹57,756 Mil.
India Glycols's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,117 Mil.
India Glycols's current Enterprise Value is ₹57,756 Mil.
India Glycols's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹38,059 Mil.
India Glycols's current Enterprise Value is ₹57,756 Mil.
India Glycols's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols Enterprise Value Related Terms
Thank you for viewing the detailed overview of India Glycols's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
India Glycols Ltd is engaged in the manufacturing and marketing of chemicals. It offers Specialty chemicals, Ethyl Alcohol (Portable), Nutraceutical and herbal extraction, Natural Gum and its derivatives, and Industrial gases, among others. The company produces chemicals through the agricultural route and manufactures ethoxylates and glycol ethers through the molasses route. The operating segments of the company are Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segment. The majority of the company's revenue is derived from its Potable Spirits segment which comprises the manufacture and sale of Ethyl Alcohol (Potable). Geographically, the company generates its key revenue from the domestic market and also has its presence overseas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:500201 has been successfully added to your 